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ABSTRACT 
 
NAD and NADP, both major carriers of cellular reducing equivalents, are of vital importance 
in diverse metabolic and signaling processes. Efficient maintenance and regulation of the 
reduction-oxidation status is therefore crucial within the cell. The only known pathway of 
NADP generation is the phosphorylation of NAD catalyzed by NAD kinase (NADK). Owing 
to the multiple roles of NADP these enzymes have gained considerable interest over the past 
few years. Genes encoding NADKs have been cloned only recently. The enzymatic activity 
has been shown to be essential for prokaryotic organisms and important for maintenance of 
the NADP pool in yeast Saccharomyces cerevisiae and plant Arabidopsis thaliana. While 
both yeast and plant encode three isoforms, only a single NADK, located in the cytoplasm, 
has been identified in mammals. Little is known about the function and regulation of NADK 
in mammalian cells. To investigate the physiological roles of NADK its expression level was 
altered in human cells. While recombinant NADK was rather specific for the oxidized form, 
NAD+, as substrate, modulation of cellular NADK activity was reflected in significant 
changes of the NADPH content. Overexpression of NADK caused a 4-5 fold increase in 
NADPH but provided only moderate protection towards oxidative stress conditions. Short-
hairpin-RNA-mediated downregulation of NADK had surprisingly little impact on cell 
proliferation, endogenous reactive oxygen species levels and cell viability after oxidant 
treatment. However, the stable shifts in the NADP redox ratio in the generated cell lines 
influenced the expression of genes known to be involved in oxidative stress response. 
Furthermore, phosphorylation of NADK in vitro mediated by calcium/calmodulin-dependent 
protein kinase II was established. The serine residue 64 was identified as phosphorylation site. 
The consequence of this modification remains unclear since no influence on the catalytic 
activity or the subcellular localization of NADK was observed. 
Two NADK isoforms, which differ only in their N-terminal sequences, were identified in the 
sea urchin Strongylocentrotus purpuratus. Importantly, for both isoforms a direct activation of 
NADK by calcium/calmodulin was demonstrated. Although the existence of calmodulin-
dependent NADKs has long been appreciated, the molecular basis of this regulation had so far 
remained unknown. Moreover, one of the isoforms was also specifically phosphorylated by 
calcium/calmodulin-dependent protein kinase II. The calmodulin-mediated activation and 
phosphorylation was associated with the different N-termini, while the catalytic domain is 
found in the identical C-terminal region of the proteins. The results suggest the N-terminal 
part of NADKs to be important as a regulatory domain. 
1 INTRODUCTION 
1.1 Metabolic roles of NAD and NADP 
Nicotinamide adenine dinucleotide (NAD) and its phosphorylated form NADP play an 
essential role in vertebrate and invertebrate cells being involved in electron transfer in various 
redox reactions (Figure 1). This electron transfer is not associated with a net consumption of 
NAD(P). Despite the little difference in the structure by only a single phosphate group, the 
redox cofactors have distinct roles in cellular pathways. NAD+ is used in catabolic reactions 
and the generated NADH provides reducing power for other metabolic pathways or ATP 
synthesis. In contrast, NADP in its reduced form is used for reductive biosynthetic pathways 
namely syntheses of fatty acids, amino acids, steroids and deoxyribonucleic acids and NADP 
is an essential cofactor for one of the fundamental processes of life, the photosynthesis in 
plant chloroplasts. NADPH is considered to be the reductive power of the cell being an 
indispensable cofactor of reductases maintaining the pool of reduced glutathione and 
thioredoxin and for detoxifying enzymes as cytochrome P450. However, NAD(P) was 
discovered to be not only an electron carrier but also a precursor for molecules involved in 
protein modification and signaling pathways (Figure 1). The knowledge of the role of 
“NAD(P)-consuming” enzymes in the regulation of important cellular functions has rapidly 
increased since then. Thus, the interest in the biosynthetic routes leading to NAD(P) 
formation and maintaining the nucleotide pools is rising. One of the crucial enzymes in the 
maintenance of the NAD(P) pool is NAD kinase. It phosphorylates NAD to NADP using 
ATP as phosphoryl donor. This reaction represents the only known way to generate NADP in 
all living organisms. 
 
Figure 1: NAD(P) as electron carrier and in regulatory reactions. (A) Structure of NAD(P). The 
nicotinamide moiety is boxed in red. The lower part shows the difference in hydrogen atoms in the nicotinamide 
moiety during reversible conversion between oxidized and reduced forms. (B) NAD(P) serves as precursor of 
messenger molecules and as substrate for covalent modifications of target molecules. 
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1.2 NAD(P)-mediated signaling 
1.2.1 NAD+ as a substrate for protein modification 
NAD+-dependent protein modification involves the cleavage of the glycolytic bond between 
nicotinamide and ADP-ribose and the subsequent ADP-ribosyl-transfer either onto proteins 
(ADP-ribosylation) or on acetate (NAD+-dependent protein deacetylation). ADP-ribosylation 
reactions are associated with two classes of enzymes: mono-ADP-ribosyltransferases (ARTs) 
and poly-ADP-ribose polymerases (PARPs). 
The family of PARPs catalyze the polymerization of ADP-ribose units from NAD+ on target 
proteins. This poly-ADP-ribosylation (Figure 2) introduces negative charges and can thereby 
alter the functional properties of modified proteins. Interestingly, poly-ADP-ribosylation 
occurs in multicellular organisms, but it is absent in prokaryotes and yeast. Poly-ADP-ribose 
metabolism regulates various biological processes, including DNA repair, maintenance of 
genome integrity, transcriptional regulation, centromer function, telomere dynamics and cell 
death (reviewed in (Bürkle, 2005; Schreiber et al., 2006)). Cell death depending on the 
overactivation of PARP-1, a nuclear enzyme, has been demonstrated to play an important role 
in a variety of pathophysiological and inflammatory conditions (Virag, 2005). Thus, the 
development of PARP-inhibitory compounds as therapeutic agents is of major interest 
(Horvath and Szabo, 2007). Recently, new PARP proteins have been identified in mammalian 
cells and have already been established as important regulators of various cellular events 
(Schreiber et al., 2006). The investigation of their physiological functions will increase the 
understanding of the cellular PAR metabolism. 
 
Figure 2: Poly-ADP-ribosylation by PARP. PARPs cleave the glycosidic bond of NAD+ between nicotinamide 
and ribose followed by the covalent modification of mainly glutamate residues of acceptor proteins with an 
ADP-ribosyl unit. PARPs also catalyze the elongation, giving rise to linear polymers with chain lengths of up to 
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about 200 ADP-ribosyl units. Some of the PARP family members catalyze a branching reaction. Modified from 
(Bürkle, 2005). 
 
Mono-ADP-ribosylation (Figure 3A) was originally identified as a catalytic activity of 
bacterial toxins, including diphtheria, cholera, pertussis and clostridial toxins (Corda and Di 
Girolamo, 2003). The modification of crucial host cell proteins interferes with their 
physiological function (Corda and Di Girolamo, 2003; Di Girolamo et al., 2005). Several 
ARTs are characterized in eukaryotes (Glowacki et al., 2002; Di Girolamo et al., 2005). 
Interestingly, ART1-ART4 are glycosylphosphatidylinositol-anchored membrane proteins 
where the catalytic domain is extracellularly located and ART5-ART7 are secreted proteins 
(Glowacki et al., 2002). These findings suggest the targets of ARTs to be primarily 
extracellular proteins. Recently, unusual intracellular ARTs were identified (Liszt et al., 2005; 
Haigis et al., 2006). They are members of the SIR2 (silent information regulator 2) family and 
do not share obvious sequence homology with ART1-7. Protein mono-ADP-ribosylation is 
involved in several regulatory processes such as signaling, immune response, cytoskeleton 
modification and membrane traffic (Corda and Di Girolamo, 2003). The consequence of this 
transfer reaction appears to be associated with an inhibition of the target proteins (Di 
Girolamo et al., 2005). For example, the enzymatic activity of mitochondrial glutamate 
dehydrogenase is inhibited by the transferase SIRT4 (Herrero-Yraola et al., 2001; Haigis et 
al., 2006) and CD38, an ectoenzyme involved in calcium signaling, is inhibited by ADP-
ribosylation (Han et al., 2000). 
 
ADP-ribose transfer has also a function in tRNA splicing. The 2’-phosphate of the splice 
intermediate is transferred to NAD+ thereby forming ADP-ribose 1’’-2’’ cyclic phosphate and 
nicotinamide (Culver et al., 1993). Whether this product has a physiological function remains 
to be established. 
 
It should be noted that NADP+ can also be used as substrate for covalent protein 
modifications. 2´-phospho-adenylation and 2´-phospho-ADP-ribosylation were reported (Hilz 
et al., 1986; Hilz, 1988) but the relevance of both was not further investigated. A recent study 
reported NADP+-dependent phospho-ADP-ribosylation of dinitrogenase reductase from 
Azotobacter vinelandii, an aerobic soil bacterium able to fix atmospheric nitrogen by 
converting it to ammonia (Ponnuraj et al., 2005). 
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The deacetylation of acetyl-lysine-modified proteins (Figure 3A) is catalyzed by Sir2-
homologues, sirtuins (Landry et al., 2000; Smith et al., 2000), a family of proteins conserved 
from bacteria to humans (Frye, 2000). Originally identified in yeast, the proteins encoded by 
SIR genes are responsible for repression of transcription at yeast mating-type loci (Rine and 
Herskowitz, 1987), telomeres (Aparicio et al., 1991) and ribosomal DNA (Fritze et al., 1997). 
Silencing is associated with deacetylated histones (Braunstein et al., 1993) and causes a 
tightly packed, inaccessible regional chromatin structure (Loo and Rine, 1994; Bi and Broach, 
1997). The requirement for NAD+ as co-substrate couples sirtuins to the metabolic status of 
the cell. Each reaction cycle generates 2’ and 3’-O-acetyl ADP-ribose (OAADPr; Figure 3A), 
nicotinamide and the deacetylated substrate (Figure 3A, (Tanner et al., 2000; Sauve et al., 
2001)). The by-product OAADPr is suggested to be a new messenger molecule (Borra et al., 
2002; Kustatscher et al., 2005; Liou et al., 2005; Grubisha et al., 2006) that may be linked to 
sirtuin-mediated pathways. Hydrolysis of OAADPr (Rafty et al., 2002; Ono et al., 2006) 
generates free ADP-ribose which may have signaling functions. 
Sir proteins regulate the lifespan in multiple model organisms. In yeast, an extra copy of the 
SIR2 gene increased the replicative lifespan, while deletion of SIR2 shortens lifespan 
(Kaeberlein et al., 1999). Increase in the dosage of Caenorhabditis elegans and Drosophila 
melanogaster Sir2 orthologues also extends lifespan (Tissenbaum and Guarente, 2001; 
Rogina and Helfand, 2004). Whether sirtuins similarly influence human aging is not known. 
Calorie restriction (CR) is a dietary regimen which is also known to mediate lifespan 
extension in yeasts, worms, flies and mammals (reviewed in (Sinclair, 2005)). CR positively 
affects age-related diseases such as cancer and auto-immune disorders (Barger et al., 2003). 
Sir2 is required for lifespan extension by CR in yeast, worms and flies (Lin et al., 2000; 
Rogina and Helfand, 2004; Wang and Tissenbaum, 2006) but Sir2-independent lifespan 
extension is also discussed (Kaeberlein and Powers, 2007). The mechanisms by which CR 
promotes NAD+-dependent activities of Sir2 might include reducing of inhibitory 
nicotinamide levels (Anderson et al., 2003), elevating NAD+ and increasing levels of Sir2. 
Mammals have seven sirtuins (SIRT1-7). However, mono-ADP-ribosyl transferase activity, 
rather than protein-deacetylation, has been reported to be the main enzymatic activity of at 
least two proteins (Liszt et al., 2005; Haigis et al., 2006). Sirtuins regulate multiple processes 
in mammalian cells (Figure 3B; reviewed in (Haigis and Guarente, 2006; Michan and 
Sinclair, 2007)) and may also be connected to CR and longevity in mammalian cells (Rose et 
al., 2003; Cohen et al., 2004; Chen et al., 2005; Nisoli et al., 2005; Zhang et al., 2007). Thus, 
sirtuins could represent novel therapeutic targets for metabolic and neurodegenerative 
diseases. In particular, sirtuin activators may positively influence health and vitality (Baur and 
Sinclair, 2006; Lagouge et al., 2006). 
 
Figure 3: Sirtuin enzymatic activities and cellular functions of mammalian sirtuins. (A) Sirtuins are NAD+-
dependent deacetylases and mono-ADP-ribosyl transferases that regulate a wide array of proteins involved in 
metabolism and cell survival. The ε-acetyl lysine residues of the target protein serve as substrates for sirtuin-
mediated deacetylation, which generates 2’ and 3’-OAADPr as a by-product. NAM, nicotinamide. (B) Sirtuins 
regulate a variety of processes in mammalian cells. AC, acetylation. Adapted from (Michan and Sinclair, 2007). 
 
1.2.2 NAD(P)+ as precursor for molecules involved in calcium signaling 
The divalent cation calcium (Ca2+) is the most common signal transduction element in 
prokaryotic and eukaryotic cells controlling many processes (Berridge et al., 2000). Unlike 
other second messenger molecules, Ca2+ cannot be metabolized therefore cells have to tightly 
regulate intracellular Ca2+ levels. The cell has two sources of Ca2+ entry, either from the 
external medium or release from internal stores, mainly the endoplasmatic/sarcoplasmatic 
reticulum (ER/SR). These Ca2+ influx mechanisms are balanced by Ca2+ pumps to remove the 
Ca2+ signal. Both processes are often organized to produce short spikes and waves of Ca2+ to 
avoid the cytotoxic effects of prolonged high intracellular Ca2+ levels. 
The release of Ca2+ from internal stores is stimulated and modulated by Ca2+ itself or the 
second messenger molecules myo-inositol 1,4,5-trisphosphate (IP3), cyclic ADP-ribose 
(cADPr; Figure 4), and nicotinic acid adenine dinucleotide phosphate (NAADP; Figure 4). IP3 
releases Ca2+ from the ER (Streb et al., 1983) after binding its receptor (IP3R). Ca2+ 
mobilization by the pyridine nucleotide derivatives was discovered shortly after (Clapper et 
al., 1987; Lee et al., 1989; Lee and Aarhus, 1995) and has been detected in several organisms 
and cell types (Lee, 2001; Guse, 2004). 
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Figure 4: Structures of Ca2+-mobilizing derivatives of NAD(P)+. Cyclic ADPr is formed from NAD+ by 
ADPr cyclase. ADPr is generated directly by NAD+ hydrolysis or by cADPr hydrolysis. NAADP formation by 
an base-exchange reaction, substituting nicotinamide for nicotinic acid, is also catalyzed by ADPr cyclase and 
the same class of enzymes synthesize cADPrP from NADP+. ADPr, ADP-ribose; cADPr, cyclic ADPr; cADPrP, 
2’-phosphate cADPr; NAADP, nicotinic acid ADP. 
 
Cyclic ADPr was shown to be an endogenous activator of Ca2+-induced Ca2+ release by 
ryanodine receptor (RyR) in the ER/SR (Galione et al., 1991) while NAADP activates 
intracellular Ca2+ channels distinct from those that are sensitive to IP3 and cADPr (Clapper et 
al., 1987; Lee and Aarhus, 1995). In the sea urchin egg, the NAADP-sensitive store appears to 
be an acidic, lysosome-related compartment (Churchill et al., 2002; Galione, 2006). This has 
been confirmed in some mammalian cell types but sensitivity of the ER/SR toward NAADP 
has also been reported (Hohenegger et al., 2002; Gerasimenko et al., 2003; Steen et al., 2007). 
Controversial discussed is the target receptor/Ca2+ channel for NAADP. Since inhibitors of 
the known IP3R and RyR do not block NAADP-mediated Ca2+ release (Chini et al., 1995; Lee 
and Aarhus, 1995), a novel channel was suggested. RyRs are also shown to be involved in 
NAADP action (Gerasimenko et al., 2003; Langhorst et al., 2004; Dammermann and Guse, 
2005). An NAADP receptor of sea urchin eggs has been partially characterized on the 
biochemical level (Berridge et al., 2002b) and the receptor is present in mammalian tissues 
(Patel et al., 2000; Zhang and Li, 2007). However, the molecular identity remains to be 
elucidated for further understanding how the multiple Ca2+-release pathways contribute to the 
generation of specific Ca2+ signals. 
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The enzymatic activity responsible for synthesizing cADPr was purified from Aplysia 
californica (Hellmich and Strumwasser, 1991) and identified as ADPr cyclase (Lee and 
Aarhus, 1991). Strikingly, although NAADP is structurally distinct from cADPr, its formation 
by a base-exchange reaction is catalyzed by the same class of enzymes (Aarhus et al., 1995). 
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As an alternative, the direct phosphorylation of NAAD by NAD kinase has been proposed 
(Ziegler, 2000). In mammalian systems, the ecto-enzymes CD38 and CD157 appear to be the 
major enzymes with ADPr cyclase activity (Schuber and Lund, 2004), although additional 
cADPr-forming enzymatic activities have been detected in brains from CD38 knockout mice 
(Ceni et al., 2003). Degradation of cADPr is also associated with ADPr cyclase activity acting 
as a glycohydrolase thereby generating ADPr. Inactivation of the messenger NAADP is 
catalyzed by a specific Ca2+-dependent phosphatase (Berridge et al., 2002a). 
During the last years, even more Ca2+-mobilizing molecules were linked to ADPr cyclases. 
2’-phospho-cADPr is generated from NADP+ (cADPrP; Figure 4) and likely acts by a similar 
mechanism as cADPr (Vu et al., 1996). Adenylic dinucleotides, synthesized from cADPr in 
the presence of adenine (Basile et al., 2005) may have cytotoxic effects (Bruzzone et al., 
2007). ADPr, generated directly by NAD+ hydrolysis or by cADPr hydrolysis (Figure 4), 
activates transient receptor potential melastatin 2 (TRPM2), a Ca2+ channel in the plasma 
membrane (Perraud et al., 2001). ADPr and TRPM2 are proposed to mediate oxidative stress-
induced cell damage (Hara et al., 2002; Perraud et al., 2005; Yang et al., 2006). 
 
1.3 Antioxidant defense systems – a key role for NADPH 
The term redox state is often used to describe the balance of thiol redox (GSH/GSSG, protein 
sulfhydryls) and pyridine nucleotide redox (NADPH/NADP+, NADH/NAD+) in the cell. The 
redox state influences many metabolic, signaling and transcriptional processes and is kept in a 
reducing state to deal with free radical intermediates, namely reactive oxygen species (ROS) 
and reactive nitrogen species (RNS). Some are highly reactive, can diffuse freely in the cell 
and oxidize cellular macromolecules thereby modulating their function. ROS include 
superoxide, hydroxyl radical and hydrogen peroxide (H2O2). Nitric oxide (NO) or its 
derivatives, in particular peroxynitrite, are considered as the major RNS. “Oxidative stress” 
results from a disturbance of the intracellular redox balance and is an important contributor in 
inflammatory processes, ischaemia/reperfusion injury, the onset of human diseases and the 
aging process (Houstis et al., 2006; Loh et al., 2006; Droge and Schipper, 2007; Valko et al., 
2007). 
ROS were classically described as harmful byproducts of aerobic metabolism. ROS, mainly 
superoxide anions, are generated in the mitochondria of eukaryotic cells during the process of 
oxidative phosphorylation (Cadenas et al., 1977) and also to a lesser extent outside the 
mitochondria. Mitochondrial ROS homeostasis plays a key role in the life and death of 
eukaryotic cells as mitochondria not only respond to ROS but also release ROS in response to 
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a number of pro-apoptotic stimuli (Jezek and Hlavata, 2005; Zorov et al., 2006). Additionally, 
cells encounter exogenous stress conditions including UV- or γ−irradiation, temperature 
changes, nutrient limitation, hypoxia and exposure to various drugs or toxins. On the other 
hand, there exist enzymes dedicated to ROS/RNS production as NAD(P)H oxidase, 
particularly in activated neutrophils and macrophages, other superoxide-producing enzymes 
and NO synthases (Nathan and Xie, 1994; Forman and Torres, 2002; Harrison, 2004). 
Furthermore, it is now obvious that transient increases of ROS and RNS act as normal 
intracellular messengers during cell growth, differentiation and even cell death (Sauer et al., 
2001). For example, H2O2 at subtoxic concentrations modifies the function of several proteins 
including transcription factors, protein kinases and phosphatases (Burdon, 1995; Thannickal 
and Fanburg, 2000; Martindale and Holbrook, 2002). The reversible oxidation of protein 
thiols in form of cysteine and methionine residues plays an important role in this redox 
regulation of cellular signaling pathways (Ghezzi, 2005). 
All cells are equipped with a variety of protective mechanisms against ROS-induced oxidative 
stress. Non-enzymatic reductants include the major thiol antioxidant glutathione (GSH), the 
small protein thioredoxin (Trx), ascorbate (Vitamin C), α-tocopherol (Vitamin E), carotenoids 
and flavonoids. Antioxidant enzymes include mitochondrial and cytosolic superoxide 
dismutases, peroxisomal catalase, and peroxidases in the mitochondria and the cytosol. These 
proteins are involved in removal of superoxide anion and H2O2 and their activities can be 
regulated according to the need of the cell to respond to increased levels of ROS. 
GSH and Trx act also as cofactors for detoxifying enzymes as GSH peroxidases, Trx 
peroxidases, peroxiredoxins, glutaredoxins, sulfiredoxin and methionine sulfoxide reductases 
(Wood et al., 2003; Chang et al., 2004; Holmgren et al., 2005; Moskovitz, 2005). All these 
systems rely on the reduced form of glutathione and thioredoxin, their regeneration is 
catalyzed by GSH reductase and Trx reductase at the expense of NADPH. Accordingly, 
NADPH is regarded as the principal cellular reductant. NADPH is also needed for formation 
of active catalase (Kirkman and Gaetani, 1984) and can act directly as an antioxidant with 
scavenging and repairing capabilities (Kirsch and De Groot, 2001). 
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1.4 Biosynthesis of NAD+ 
Four different precursors derived from the diet and the cellular catabolism contribute to NAD+ 
synthesis (Figure 5; (Rongvaux et al., 2003; Bieganowski and Brenner, 2004; Magni et al., 
2004)). The pathways leading to NAD+ synthesis can be divided in de novo pathway, 
nicotinic acid (NA) import pathway and salvage pathways from nicotinamide (Nam) and 
nicotinamide riboside (NamR). Since NAD+-consuming enzymes, as PARP, CD38 and 
ART/sirtuin, can be inhibited by Nam, the salvage of Nam is of major importance. In 
addition, recycling of Nam can save the energy which is required for de novo NAD+ 
synthesis. Tryptophan, an essential amino acid, is used in the de novo generation of NAD+ in 
most living organisms. It is converted in several steps to quinolinic acid (QA) and further to 
nicotinic acid mononucleotide (NAMN). NAMN is also formed from NA by NA 
phosphoribosyltransferase (NAPRT). NAMN is then adenylated by NMN/NAMN 
adenylyltransferase (NMNAT) and resulting desamido-NAD (NAAD) is converted into 
NAD+ by glutamine-dependent NAD synthase (NADS). 
Apparently, the Nam salvage pathway diverged in eukaryotes. Nam may represent the main 
source of NAD for most mammalian cells. It is converted by Nam phosphoribosyltransferase 
(NamPRT) to NMN, which is further adenylated to NAD+ by NMNAT. In contrast, 
eukaryotes including yeast, plant, worm and fly and many bacteria convert Nam to NA 
through nicotinamidase (NDase). No obvious homologues of NDase have been found in 
vertebrates (Rongvaux et al., 2003). 
Recently, it was shown that fungi and vertebrates salvage NamR, a vitamin precursor of 
NAD, which occurs in milk (Bieganowski and Brenner, 2004). NamR is phosphorylated by 
NamR kinase (NRK) and the generated Nam mononucleotide (NMN) is converted to NAD+ 
by NMNAT. At least in yeast, NamR can also be cleaved to yield free Nam (Belenky et al., 
2007). 
 Figure 5: Biosynthesis of NAD(P)+. Four different precursors (red) contribute to the known pathways of NAD+ 
biosynthesis. Nicotinamidase (NDase) is found in yeast, plant and C. elegans but is absent in mammals. NA, 
nicotinic acid; NAAD, NA adenine dinucleotide; Nam, nicotinamide; NAMN, NA mononucleotide; NamR, Nam 
riboside; NMN, nicotinamide mononucleotide; QA, quinolinic acid; Trp, tryptophan. 
 
The primary structures of eukaryotic enzymes involved in NAD+ biosynthesis are well known 
(Berger et al., 2004; Bieganowski and Brenner, 2004; Magni et al., 2004). Interestingly, three 
NMNAT isoforms are identified in humans and shown to be expressed in the nucleus, the 
Golgi apparatus and the mitochondria (Berger et al., 2005) thus suggesting organelle-specific 
NAD+ biosynthesis. Increased NMNAT-1 activity did not result in changes of cellular NAD+-
levels (Anderson et al., 2002; Revollo et al., 2004) but can protect axons from mechanical and 
toxic insults (Araki et al., 2004). SIRT1 was suggested as effector of this axonal protection 
(Araki et al., 2004) however SIRT1-independent local mechanisms might also be involved 
(Wang et al., 2005). NamPRT, also known as pre-B-cell colony-enhancing factor (PBEF), is 
located in the cytosol and extracellular (Rongvaux et al., 2002). While overexpression of 
NamPRT increases NAD+ concentrations and has cell-protective benefits (Revollo et al., 
2004; van der Veer et al., 2005), extracellular NamPRT might convert Nam produced by 
extracellular cADPr synthases. Increased dosage of NaPRT and NDase increased longevity of 
yeast but had no influence on cellular NAD+ levels (Anderson et al., 2002; Anderson et al., 
2003). Knock-down of NDase in C. elegans is associated with decreased lifespan (van der 
Horst et al., 2007) and NDase-deficient plants have lower levels of NAD(P) (Wang and 
Pichersky, 2007). Increasing the dosage of NDase increased the survival of C. elegans under 
conditions of oxidative stress (van der Horst et al., 2007). 
In conclusion, NAD+ or its precursors might have protective effects for health or in a variety 
of human diseases and enzymes involved in NAD+ metabolism are suggested to be attractive 
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targets for drug discovery (Khan et al., 2007). However, further studies are needed to 
completely understand the contribution of NAD+-mediated pathways. 
 
1.5 NADK – the essential enzyme for NADP biosynthesis 
NAD kinase (NADK) catalyzes the phosphorylation of NAD to NADP using ATP or 
inorganic polyphosphate as phosphoryl donors. This reaction represents the only known way 
to generate NADP in prokaryotic and eukaryotic cells. NADP synthesis was first reported in 
yeast homogenates (Vestin, 1937; von Euler and Adler, 1938). Later, the enzyme was 
partially purified and characterized from yeasts, mammals, plants and sea urchin 
(McGuinness and Butler, 1985). However, conclusive structural information has only recently 
become available after identification of the amino acid sequences of Mycobacterium 
tuberculosis and Micrococcus flavus NADKs (Kawai et al., 2000). To date, NADKs of Homo 
sapiens, yeast S. cerevisiae, plant Arabidopsis thaliana and multiple prokaryotes have been 
characterized (reviewed in (Magni et al., 2006; Pollak et al., 2007)). NADK is an essential 
enzyme as has been demonstrated in Escherichia coli, M. tuberculosis, Bacillus subtilis and 
Salmonella enterica (Gerdes et al., 2002; Kobayashi et al., 2003; Sassetti et al., 2003; Grose et 
al., 2006) and in the yeast S. cerevisiae (Bieganowski et al., 2006; Shianna et al., 2006). 
Furthermore, embryonic lethality upon loss of both alleles in mouse is reported as an 
unpublished observation (Shianna et al., 2006). 
1.5.1 Structural properties of NADK 
The comparison of known NADK amino acid sequences shows a highly conserved region, the 
catalytic domain, within the C-terminus of the proteins whereas the N-terminal parts vary and 
are significantly longer in eukaryotic NADKs (Figure 6). The catalytic domain (Pfam 
PF01513) is characterized by two well-conserved motifs, the GGDG motif and a glycine-rich 
motif. The GGDG motif is also found in diacylglyceride kinase, sphingosine kinase and 6-
phosphofructokinase thereby proposed to be a feature of a kinase superfamily including 
NADK (Labesse et al., 2002). The importance of both motifs for the enzymatic activity was 
confirmed by site-directed mutagenesis of amino acid residues within the motifs (Labesse et 
al., 2002; Raffaelli et al., 2004; Mori et al., 2005b) and was further supported by three-
dimensional structures of prokaryotic NADKs (Garavaglia et al., 2004; Liu et al., 2005; Mori 
et al., 2005b; Oganesyan et al., 2005; Poncet-Montange et al., 2007). 
 
 Figure 6: Partial multiple alignment of NADKs from several organisms. Amino acid sequences of human 
NADK (protein ID NP_075394); A. thaliana NADK-1, NADK-2 and NADK-3 (NP_974347, NP_564145 and 
NP_177980); S. cerevisiae NADK-1, NADK-2 and NADK-3 (P21373, NP_010873 and NP_015136); E. coli 
NADK (NP_417105); and M. tuberculosis NADK (BAB21478) were compared using Clustal W. Identical and 
similar residues are highlighted in black and grey respectively. The two conserved NADK motifs are boxed in 
red. Modified from (Pollak et al., 2007). 
 
While several three-dimensional structures of prokaryotic NADKs have been resolved (Figure 
7), no eukaryotic one is yet reported. M. tuberculosis NADK is a biological tetramer and 
corresponds to a dimer of dimers (Garavaglia et al., 2004; Mori et al., 2005b). The overall 
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structure is organized into an N-domain, a C-domain and a C-terminal tail. The N-terminal 
domain resembles a classical Rossmann fold, known to be involved in dinucleotide binding 
(Rossmann et al., 1974), consisting of a single parallel β-sheet flanked by α-helices. The C-
terminal domain adopts a novel fold with structural similarity to the human Ki67 fork-head-
associated domain (Garavaglia et al., 2004). The structures of Archaeoglobus fulgidus and 
Listeria monocytogenes NADKs show similarities, two dimers assemble a tetramer (Liu et al., 
2005; Poncet-Montange et al., 2007). The substrates NAD+ and ATP and the product NADP+ 
are all bound to a cleft between the N- and C-domains. Subunit interactions are required for 
ligand binding (see Figure 7B; black broken line). Indeed, known NADKs are homo-
oligomeric proteins as determined by gel filtration experiments. 
A phosphate transfer mechanism based on substrate-assisted catalysis was suggested (Poncet-
Montange et al., 2007), however further studies are needed to completely understand the 
reaction mechanism for NADKs. In particular, it will be necessary to determine the crystal 
structure of the human NADK. Comparison of its structural, catalytic and kinetic properties 
with NADKs of highly pathogenic organisms could represent an important step for 
development of novel antibacterial drugs. 
 
Figure 7: Crystal structures of prokaryotic NADKs. (A) Stereo ribbon representation of the MtNADK 
subunit. Residues of the GGDG sequence fingerprint and of the second conserved region are colored in red and 
blue, respectively. Residues proposed to be involved in the NAD binding are drawn in a ball-and-stick 
representation. Ct, C terminus; Nt, N terminus. Modified from (Garavaglia et al., 2004). (B) Ribbon model of 
quaternary structure of MtNADK-NAD. An asymmetric unit contained 2 subunits (MtNADK-NAD-A/-B, or –
A’/B’). NAD is indicated in red (nitrogen, blue; phosphorus, pink). The A-A’ and B-B’ contact regions are 
enclosed by black broken line. MtNADK-flexible loops are shown in yellow. Modified from (Mori et al., 2005b). 
(C) Molecular surface model of quaternary structure of MtNADK-NAD as shown in (B), but was rotated by 
90°C. NAD is shown in light blue. Surfaces of residues involved in NAD binding are colored in green (Thr200-
Ser205), yellow (Asn159, Glu160), and pink (Asp85, Gly86). Modified from (Mori et al., 2005b). (D) Ribbon 
diagram of the AfNADK tetramer in complex with ATP. The individual monomers are labeled as A, A’, B and 
B’. Modified from (Liu et al., 2005). 
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1.5.2 Enzymatic properties of NADK 
NADK has an absolute requirement for divalent metal ions. The enzymes from both, 
prokaryotic and eukaryotic organisms utilize nucleoside triphosphates, preferentially ATP, as 
phosphoryl donor for catalysis. Interestingly, some bacterial enzymes, for example from M. 
tuberculosis, M. flavus and B. subtilis, can also utilize inorganic polyphosphate (poly(P)) 
(Magni et al., 2006; Pollak et al., 2007). Poly(P) is present in nearly all living organisms and 
considered to be an ‘ancient’ energy carrier preceding ATP (Kornberg, 1999). Even glucose-
6-phosphate-dependent bacterial NADKs have been described (Bark et al., 1993), but were 
not investigated further. The question how the bacterial NADKs distinguish between the 
phosphoryl donors has not been answered yet but may represent a key to the development of 
new specific antibacterial drugs. In particular the mycobacterial enzyme could be an attractive 
and novel drug target for the treatment of tuberculosis. NADK is essential for M. tuberculosis 
(Sassetti et al., 2003) and exhibits higher affinity towards poly(P) than ATP (Raffaelli et al., 
2004). Relatively high KM values for ATP have been reported for E. coli, S. enterica and 
human NADKs, suggesting a regulation of their activity according to physiological changes 
of the cellular ATP concentration, which is in the millimolar range. 
Several recombinant enzymes have been shown to phosphorylate only NAD+, but hardly 
NADH, thus displaying strict substrate selectivity. Others exhibit a far less stringent substrate 
specificity and use both the oxidized and reduced nucleotide however with different 
efficiency (reviewed in (Magni et al., 2006; Pollak et al., 2007)). Significant differences in 
substrate selectivity as reported for plant NADKs may have arisen from the assay conditions 
used. What determines this difference in specificity regarding the substrate NAD? A previous 
report suggested that a single amino acid residue in the conserved domain of NADK 
homologues is responsible for substrate specificity (Mori et al., 2005a). Relaxed substrate 
specificity is associated with a glycine or polar amino acid residue while an arginine, as well 
as charged and hydrophobic residues might be responsible for strict NAD+-specificity. Indeed, 
substitution of the corresponding arginine residue in NAD+-specific NADK from E. coli 
resulted in activity towards NADH but accounted only for ~3% of the original activity (Mori 
et al., 2005a). Multiple sequence alignment analysis reveals dominantly polar amino acid 
residues in eukaryotic homologues including human NADK at the investigated position (see 
Figure 6, red asterisk). This suggests mainly relaxed substrate specificity for these NADKs. 
Human NADK was shown to efficiently phosphorylate NAD+ (Lerner et al., 2001). Whether 
the enzyme does utilize NADH was not investigated before. 
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1.5.3 Modulation of NADK activity 
The enzymatic activity of NADKs is modulated in different ways. Several NADKs are 
inhibited by the reduced pyridine nucleotides (Kawai et al., 2001a; Kawai et al., 2001b; 
Raffaelli et al., 2004; Shi et al., 2005; Grose et al., 2006) and by high concentrations of 
NADP+ (Garavaglia et al., 2003; Ochiai et al., 2004; Raffaelli et al., 2004). NADP and NADH 
inhibit S. cerevisiae NADKs to different extents suggesting a possible regulation by these 
compounds (Shi et al., 2005). NADK of S. enterica is inhibited by NADPH during normal 
growth and is released from the inhibition in response to metabolic changes induced by UV 
irradiation or oxidative stress (Grose et al., 2006). Quinolinate, a metabolite in NAD 
biosynthesis, was shown to inhibit NADK of S. enterica serotype Typhimurium (Cheng and 
Roth, 1994) and to activate B. subtilis NADK (Garavaglia et al., 2003), but had no effect on 
human NADK (N. Pollak and M. Ziegler, unpublished work). Several NADKs are strongly 
inhibited by thiol-group modifying reagents, indicating that an SH-group of the enzyme is 
likely involved in catalysis (Delumeau et al., 2000; Kawai et al., 2001b; Garavaglia et al., 
2003; Ochiai et al., 2004; Shi et al., 2005; Turner et al., 2005). 
A connection between NADK activity and calcium/calmodulin (Ca2+/CaM) is well known for 
decades, at least for the enzymes from sea urchin eggs (Epel et al., 1981), plants (Anderson et 
al., 1980) and human neutrophils (Williams and Jones, 1985). Surprisingly, the molecular 
mechanism of this activation has not been elucidated yet. NADK in sea urchin eggs is 
activated by Ca2+/CaM early after fertilization, resulting in a shift in the NADPH/NADP+ 
ratio from 1:1 to 3-6:1 (Epel, 1964; Schomer and Epel, 1998). Increased levels of NADPH 
may be important for DNA and protein syntheses (Whitaker and Steinhardt, 1981; Standart et 
al., 1985; Akkaraju et al., 1991). Moreover, increased NADPH levels lead to an increase of 
H2O2 production via NADPH oxidase (Foerder et al., 1978; Heinecke and Shapiro, 1989). 
H2O2 has a role in hardening of the fertilization membrane (Foerder and Shapiro, 1977). 
NADK activity has been partially purified from sea urchin eggs (Blomquist, 1973) but the 
molecular identity of the enzyme is not known. 
Plants possess both CaM-dependent and –independent NADK isoforms that differ in their 
subcellular localization (Simon et al., 1982; Dieter and Marme, 1984; Simon et al., 1984; Pou 
De Crescenzo et al., 2001). However, the activity of the three recombinant NADK isoforms 
from A. thaliana was not influenced by Ca2+/CaM although AtNADK-2 binds CaM in a Ca2+-
dependent manner (Turner et al., 2004; Turner et al., 2005). CaM has also no detectable effect 
on the activity of human recombinant NADK (Lerner et al., 2001). In contrast, a partially 
purified NADK from human neutrophils was shown to be activated by Ca2+/CaM (Williams 
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and Jones, 1985). These observations suggest that the activation of NADK by Ca2+/CaM 
might be indirect and requires additional factors or the existence of so far not identified 
NADK isoforms in human cells and plants. 
1.5.4 Subcellular localization and physiological roles of eukaryotic NADKs 
Mammals – NADK activity has been reported in several fractions of various mammalian 
tissues (McGuinness and Butler, 1985). However, enrichment of NADK activity in bovine 
liver was only detectable after a high-speed centrifugation step of the homogenate (Lerner and 
Ziegler, unpublished). The subcellular localization of the characterized enzyme from H. 
sapiens (Lerner et al., 2001) has yet not been established. The protein is predicted to be 
localized to the cytosol (PSORT II, (Nakai and Horton, 1999)) as no putative subcellular 
targeting sequences are found. It should be noted that the human genome harbours two 
putative NADK homologues. One cDNA sequence (GenBank AF250320) could represent an 
alternatively spliced form. Attempts to isolate this respective nucleotide sequence from 
various human cell lines have not been successful (Berger and Ziegler, unpublished). The 
second cDNA sequence (GenBank NM_153013) obviously lacks the 5’-region since the 
highly conserved GGDG motif is not present. Attempts to isolate additional 5’-sequence have 
not been successful yet (Berger, Pollak and Ziegler, unpublished). Tissue-specific expression 
of the NADK mRNA revealed only one band at the expected size in most tissues (Lerner et 
al., 2001). 
Relatively little is known about the physiological role of NADK in mammals. NADK activity 
showed dramatic temporal and spatial variations during development of rat conceptus (Akella 
and Harris, 2001), reflecting the importance of maintaining the cellular redox state during 
organogenesis. Indeed, mouse embryonic lethality upon NADK loss was reported as an 
unpublished observation (Shianna et al., 2006). Furthermore, NADK activity may have an 
important role in the mitogenic response of immune cells (Williams and Jones, 1985; Berger 
et al., 1987; Iqbal and Zaidi, 2006). 
 
Yeast – The presence of NADK activity in the cytoplasm and mitochondria of yeast is long 
established (McGuinness and Butler, 1985). Three NADK isoforms in S. cerevisiae have been 
characterized recently. ScNADK-1 and ScNADK-2 are cytosolic proteins and exhibit relaxed 
substrate specificity with some preference towards NAD+ (Kawai et al., 2001b; Shi et al., 
2005) whereas ScNADK-3 localizes to the mitochondrial matrix and prefers NADH as 
substrate (Outten and Culotta, 2003). A global analysis of protein expression in yeast revealed 
ScNADK-2 to be less present (~300 molecules per cell) compared to ~5000 molecules of 
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isoform 1 and 3 (Ghaemmaghami et al., 2003). In agreement, ScNADK-1 and ScNADK-3 are 
responsible for almost all NADK activity in vivo since the disruption of both is synthetically 
lethal, with or without the deletion of isoform 2 (Bieganowski et al., 2006; Shianna et al., 
2006). The double mutant can be rescued by overexpression of any of the yeast NADK 
isoforms (Bieganowski et al., 2006) or human NADK (Shianna et al., 2006). Notably, 
ScNADK-3, the mitochondrial isoform, was established as the most critical generator of 
NADPH in yeast. Yeast cells deleted for this isoform are highly sensitive towards oxidative 
stress induced by hydrogen peroxide or hyperoxia (Krems et al., 1995; Outten and Culotta, 
2003). ScNADK-3 mutants exhibit increased frameshift mutations in the mitochondrial DNA 
and increased petite colony formation (Strand et al., 2003). Deletions strains accumulate iron 
in the mitochondria and are defective in mitochondrial Fe-S cluster-containing enzymes 
(Outten and Culotta, 2003) leading to upregulation of genes involved in iron transport 
(Shianna et al., 2006). In contrast, disruption of ScNADK-1 or ScNADK-2 does not result in 
severe growth defects or in hypersensitivity to high oxygen concentration (Outten and 
Culotta, 2003). ScNADK-1 is suggested to provide NADP for cytosolic NADP-dependent 
dehydrogenases and detoxifying systems while the role of isoform 2 remains rather unclear 
(Bieganowski et al., 2006). 
 
Plants – NADK activity has originally been associated with cytoplasmic (Simon et al., 1982), 
mitochondrial (Dieter and Marme, 1984) and chloroplastic fractions (Muto and Miyachi, 
1981; Jarrett et al., 1982). Based on sequence similarity with NADKs from other organisms, 
three genes encoding putative NADKs were predicted in the A. thaliana genome (Hunt et al., 
2004) and subsequently cloned and characterized (Turner et al., 2004; Turner et al., 2005). 
AtNADK-1 and AtNADK-3 are expressed in most tissues, while isoform 2 is only expressed 
in leaves (Turner et al., 2004; Berrin et al., 2005). Recent studies on the localization of 
overexpressed green fluorescent protein-NADK constructs in plant revealed AtNADK-2 to be 
targeted to the chloroplasts (Chai et al., 2005) while AtNADK-1 and AtNADK-3 are found in 
the cytoplasm (Chai et al., 2006). 
Plant NADK isoforms respond differently to stress conditions. Irradiation or treatment with 
hydrogen peroxide of plant cell suspensions induced AtNADK-1 mRNA and protein levels 
(Berrin et al., 2005). The transcript of AtNADK-3 is induced by cold, osmotic stress, a 
superoxide-generating agent and high salinity whereas the transcript levels of AtNADK-1 and 
AtNADK-2 were not significantly affected by these conditions (Chai et al., 2006). Plants 
deficient for AtNADK-1 exhibit increased sensitivity to oxidative stress (Berrin, 2005). The 
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knockout of NADK-2 in A. thaliana delays growth and development, resulting in reduced leaf 
size and seed production. NADK activity and NADP(H) content was significantly lowered in 
leaves of the mutant compared to wild-type (Takahashi et al., 2006). AtNADK-2 protects 
chloroplasts against oxidative stress and plays a vital role in chlorophyll synthesis according 
to the importance of NADP in photosynthesis (Chai et al., 2005). Knockout of AtNADK-3 
enhanced the plants sensitivity to various stress conditions (Chai et al., 2006). Under these 
conditions the mutant plants show significantly decreased NADPH level and GSH/GSSG 
ratio and increased expression of stress marker genes compared to wild-type plants. 
 
In summary, these observations establish significant differences for maintenance of the 
NADP pool in different organelles in yeast compared to human and plant cells. The fact that 
the yeast S. cerevisiae apparently lacks the enzyme transhydrogenase makes a separate 
NADPH production in the mitochondria necessary. The direct utilization of NADH for 
generation of NADPH may be reflected by the oxidation state of NADH. In yeast cells ~50% 
of the total cellular NAD(H) is in the reduced form, and this may also be the case for the 
mitochondrial NAD(H) pool (Ting et al., 1977). In contrast, only 10-20% of the total cellular 
NAD(H) is in the reduced form in mammalian cells. Furthermore, yeast mitochondria possess 
an NADP phosphatase activity more active towards the reduced form (Bernofsky and Utter, 
1968) and can take up NAD+ from the cytosol (Todisco et al., 2006) which might facilitate the 
recycling of NAD+ back into the tricarboxylic acid cycle. However, it remains possible that 
mammalian and plant mitochondria also possess an NADK to generate NADP, although such 
an enzyme has not been identified to date. 
 
1.6 Redox-reactions generating NADPH 
Besides a direct phosphorylation of NADH by NADKs several NADP+-specific 
dehydrogenases, as well as nicotinamide nucleotide transhydrogenase have been identified as 
significant contributors to the cellular NADPH pool (Figure 8). 
1.6.1 Glucose-6-phosphate dehydrogenase 
Glucose-6-phosphate dehydrogenase (G6PD), the key regulatory enzyme of the cytosolic 
pentose phosphate pathway, catalyzes the oxidation of glucose-6-phosphate to 6-phospho-
gluconolactone and the production of reducing equivalents in form of NADPH. The 
importance of G6PD is illustrated by clinical manifestations of its deficiency. This common 
enzymopathy, affecting over 200 million people worldwide, is the cause of haemolytic 
anaemia (Beutler, 1991). Furthermore, G6PD might be linked to diabetes. Hyperglycemia 
causes inhibition of G6PD activity thus lowered NADPH levels and increases oxidative stress 
(Xu et al., 2005; Diaz-Flores et al., 2006). Oxidative stress can induce damage of pancreatic 
β-cells and is believed to be involved in type 2 diabetes (Robertson and Harmon, 2006). 
In human cell lines exposed to H2O2 or diamide both G6PD activity and mRNA level are 
rapidly and transiently enhanced (Ursini et al., 1997) and salt stress in plants increased G6PD 
activity and protein (Valderrama et al., 2006). This suggested G6PD to be part of a 
mechanism to protect cells against oxidative damage. Indeed, G6PD overexpression confers 
strong protection against H2O2-induced cell death through induction of GSH production 
(Salvemini et al., 1999; Tian et al., 1999). Conversely, inhibition of G6PD activity potentiated 
H2O2-induced cell death (Tian et al., 1999). Surprisingly, the knockout of the G6PD gene in 
yeast or mouse embryonic stem cells produced viable cells (Nogae and Johnston, 1990; 
Pandolfi et al., 1995; Filosa et al., 2003) while mouse embryos lacking G6PD fail to develop 
normally (Longo et al., 2002). Yeast and mouse cells deleted for the G6PD gene (∆G6PD) are 
more sensitive to oxidizing agents than control cells (Nogae and Johnston, 1990; Pandolfi et 
al., 1995; Filosa et al., 2003). Mouse ∆G6PD cells were able to maintain high 
[NADPH]/[NADP+] and [GSH]/[GSSG] ratios under normal culture conditions but oxidative 
stress resulted in a dramatic reduction of both ratios in ∆G6PD cells compared to wild-type 
cells (Filosa et al., 2003). G6PD-deficient cell lines were shown to undergo premature cellular 
senescence (Ho et al., 2000). 
In summary, G6PD has an important role in antioxidant defense mechanisms. However 
NADPH produced by a cytosolic enzyme is unavailable to mitochondria, the major site of 
superoxide production. Thus, other NADP+-specific dehydrogenases have been identified as 
major sources of NADPH supply. 
 
Figure 8: Generation of NADP in eukaryotic cells. G6PD, glucose-6-phosphate dehydrogenase; IDP, NADP+-
dependent isocitrate dehydrogenase; ALDH, NADP+-dependent aldehyde dehydrogenase; ME, NADP+-
dependent malic enzyme; ∆p, electrochemical proton gradient. 
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1.6.2 Isocitrate dehydrogenase 
NADP+-dependent isocitrate dehydrogenase (IDP) catalyzes the oxidative decarboxylation of 
isocitrate, producing α-ketoglutarate and CO2. Two isoforms were identified in mammals, 
localized to the mitochondria (IDPm) and the cytosol (IDPc) (Plaut et al., 1983) although the 
latter has also been found in peroxisomes (Yoshihara et al., 2001). Interestingly, IDPc in rat 
liver was shown to be 16-18fold more active in NADPH production than G6PD (Veech et al., 
1969). Several reports have confirmed that the isoforms play a key role in the control of 
cytosolic and mitochondrial redox balance through the supply of NADPH for regeneration of 
GSH and reduced Trx in both compartments. IDPm activity and protein level are upregulated 
after treatment with H2O2 (Jo et al., 2001) and the activity of both isoforms is increased by γ-
irradiation (Lee et al., 2004). The overexpression of either isoform protected the cells from 
oxidative damage induced by oxidizing agents (Jo et al., 2001; Lee et al., 2002), γ-irradiation 
(Lee et al., 2004), cadmium (Kil et al., 2006) or heat-shock (Kim et al., 2005). Conversely, 
downregulation of IDP at the mRNA level potentiated ROS production and oxidative damage. 
Three IDP homologues were identified in yeast and localized to mitochondria (Haselbeck and 
McAlister-Henn, 1991), cytosol (Loftus et al., 1994) and peroxisomes (Henke et al., 1998). 
The mitochondrial and cytosolic isoforms are not essential, even in the context of G6PD 
deletion (Minard et al., 1998). The peroxisomal IDP is involved in metabolism of unsaturated 
fatty acids (Henke et al., 1998). 
In plants, four IDP isoforms have been described with different subcellular localizations: 
mitochondria, chloroplast, peroxisomes and cytosol (Galvez et al., 1999), however the 
cytosolic enzyme is the predominant form (Chen, 1998). This isoform may have a protective 
antioxidant role since activity and protein level are upregulated under salt stress (Valderrama 
et al., 2006) and oxidative stress induced by paraquat (Marino et al., 2007). 
1.6.3 NADP+-dependent malic enzyme and aldehyde dehydrogenase 
Two malic enzyme isoforms have been described in mammalian tissues and were localized to 
the cytosol and the mitochondria (Frenkel, 1971; Bukato et al., 1995). Cytosolic malic 
enzyme activity is increased in rat liver cirrhogenesis (Sanz et al., 1997) and affected in acute 
hepatic injury (Diez-Fernandez et al., 1996), presumably by providing NADPH for 
detoxification reactions. The mitochondrial isoform plays an important role in the pyruvate-
recycling pathway and in maintaining the intramitochondrial GSH in the brain (McKenna et 
al., 2000). In pancreatic islets, the mitochondrial pyruvate-malate shuttle could contribute far 
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more to NADPH generation than the cytosolic pentose phosphate pathway (MacDonald, 
1995). 
Yeast malic enzyme is a mitochondrial protein (Boles et al., 1998). Disruption of the 
corresponding gene did not result in an observable growth phenotype (Boles et al., 1998), nor 
did it worsen the growth phenotypes of G6PD and IDP deletion strains (Minard et al., 1998). 
Aldehyde dehydrogenases (ALDHs) are a group of NAD(P)+-dependent enzymes that are 
important for detoxification of aldehyde substrates. ALDHs are upregulated in response to 
oxidative stress and several mutations in ALDH genes have been linked to cancer and 
Alzheimer’s disease (Vasiliou and Nebert, 2005). ALDH isoforms may play a role in cellular 
defense mechanisms (Pappa et al., 2003; Choudhary et al., 2005). However, whether 
mammalian ALDHs have a general role in the maintenance of NADPH has to be investigated. 
There is little information available on the antioxidant properties of NADP+-dependent 
ALDHs in yeast cells. Initially, disruption of the genes encoding Ald6, a cytosolic enzyme, 
and G6PD was thought to be lethal (Grabowska and Chelstowska, 2003) but it was shown 
later that co-disruption of both is not lethal (Minard and McAlister-Henn, 2005). 
1.6.4 Nicotinamide nucleotide transhydrogenase 
Nicotinamide nucleotide transhydrogenases (NNT) of mammalian mitochondria and bacteria 
are membrane-bound enzymes that catalyze the direct transfer of a hydride ion between 
NAD(H) and NADP(H) in a reaction that is coupled to transmembrane proton translocation 
[H+out + NADH + NADP+ º H+in + NAD+ + NADPH]. Under physiological conditions the 
equilibrium of this reaction is shifted towards NADPH formation. The contribution of NNT to 
the NADPH pool was estimated to be 35-45% in E. coli (Sauer et al., 2004). In mammalian 
mitochondria, the contribution is assumed to be at least as high or higher. An important 
function of NNT is the generation of a high NADPH/NADP+ and thus GSH/GSSG ratio 
which is critical for protection of mitochondria against oxidative stress (Hoek and Rydstrom, 
1988). Indeed, knockout of NNT in C. elegans resulted in mutant nematodes with highly 
decreased GSH/GSSG ratio and increased sensitivity to conditions of oxidative stress 
(Arkblad et al., 2005). Recently, a link between NNT and diabetes was demonstrated (Toye et 
al., 2005; Freeman et al., 2006). The diabetic characteristics of C57BL/6J mice were linked to 
a mutated Nnt gene resulting in lack of the NNT protein (Toye et al., 2005) and an elevated 
level of ROS in β-cells (Freeman et al., 2006). Thus, the C57BL/6J mice may provide a 
model for human type 2 diabetes. 
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2 AIMS OF THE STUDY 
 
NAD kinase is suggested to play a key role in the maintenance of the cellular redox status. 
Relatively little is known about the functions and regulation of NADK in mammalian cells. 
Therefore, a major goal of the work presented in this thesis was to identify the physiological 
roles of the known human NADK and the molecular mechanisms regulating NADK activity 
in mammalian cells. The cellular function of NADK was investigated by modulation of its 
abundance by overexpression or short-hairpin-RNA-mediated knock-down with subsequent 
analyses of the cell’s phenotype, the redox-ratio of NADP and the ability to cope with 
oxidative stress situations. 
 
The regulation of NADK activity by Ca2+/CaM in extracts of plants and human neutrophils 
has long been known. However, the molecular mechanism of the CaM-dependent activation 
of NADK has not been established. Neither the recombinantly expressed human enzyme nor 
the plant NADK isoforms displayed sensitivity towards Ca2+/CaM. Thus I speculated that 
CaM may act indirectly on NADK. Therefore, I tested the possibility that the human NADK 
is substrate for a Ca2+/CaM-dependent phosphorylation which could affect the catalytic 
activity of the enzyme. 
Since NADK in sea urchin eggs is also known to be activated in a CaM-dependent manner I 
was interested in studying the molecular mechanism of this activation. However, the 
molecular identity of the enzyme was not known at the beginning of this project. In 2006, the 
complete sequence and analysis of the genome of the sea urchin Strongylocentrotus 
purpuratus was reported (“Science” Vol. 314). I aimed at identifying and cloning the 
respective sea urchin NADK cDNA sequence and to characterize this enzyme. In particular, I 
was interested whether CaM regulates sea urchin NADK activity directly. 
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3 SUMMARY OF RESULTS 
3.1 Functional consequences of NADK up- and downregulation in human cells 
The study published in Paper I describes the cellular consequences on manipulating the 
expression level of cytoplasmic NADK in human cells. HEK293 cell lines stably 
overexpressing NADK or small-hairpin-RNA targeting the NADK mRNA were generated. 
Cells stably overexpressing an unrelated small-hairpin-RNA directed against the mRNA of 
enhanced green fluorescent protein were used as control cells. The stable overexpression of 
NADK in HEK293 cells resulted in an almost 200-fold increase of NADK transcript level, 
protein level and catalytic activity. On the other hand, stable knock-down of NADK was 
followed by a decreased level of NADK transcript and protein and consequently, reduced 
NADK activity. This efficient downregulation of the single known NADK mRNA had no 
significant effect on cell proliferation under normal conditions. 
NADK recombinantly expressed in bacteria was rather specific for NAD+ as substrate and 
phosphorylated NADH less efficiently. However, modulation of NAD kinase expression in 
human cells was shown to have an effect on the cellular NADPH content, while the NADP+ 
concentration was not significantly altered. NADK overexpression was followed by a 4-5 fold 
increase in the NADPH content, whereas the concentration of this nucleotide was about 
threefold decreased in the knock-down cells. Next, I investigated whether this significant 
increase of NADPH resulted from upregulation of NADP+-dependent dehydrogenases. 
Measurements of the relative mRNA levels of NADP+-reducing enzymes of the cytosolic 
pentose phosphate pathway revealed only slight changes. The activity of G6PD, the rate-
limiting enzyme of this pathway, was also not changed in reponse to NADK overexpression 
or knock-down. 
As one consequence of the altered NADPH concentration, the level of intracellular reactive 
oxygen species (ROS) correlated with the level of NADK activity. Overexpression of NADK 
resulted in a decrease of about 20% and knock-down of NADK was followed by an ~25% 
increase in endogenous ROS amount compared to control cells. To monitor the capability of 
the three cell lines to deal with oxidative stress, two agents were used to elevate ROS levels: 
menadione, which generates superoxide radicals through a cycling reaction and hydrogen 
peroxide, a source of peroxide radicals. Treatment of the NADK knock-down cells resulted in 
slightly higher ROS level with respect to control cells whereas the ROS level was 
significantly lower in cells overexpressing NADK. 
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Secondly, the NADK expression and concomitantly the NADPH levels had surprisingly little 
effect on ROS-induced damage. The different cell lines were exposed to hydrogen peroxide or 
menadione and cell survival was determined 24 hours after the treatment. NADK upregulation 
increased resistance against hydrogen peroxide-induced cell death while this protective effect 
was not observed for menadione treatment. On the other hand, cell survival after treatment of 
NADK knock-down cells was comparable to that of control cells. 
Thirdly, the presented results provide evidence that the NADK expression level influences the 
expression of genes known to be involved in oxidative stress response, namely peroxiredoxin 
5 (PRDX5) and NF-E2-related factor 2 (Nrf2). PRDX5 is a thioredoxin peroxidase catalyzing 
the reduction of hydrogen peroxide, alkyl hydroperoxides and peroxynitrite, and is therefore 
important in cellular antioxidant defense and hydrogen peroxide-mediated signaling 
pathways. The transcription factor Nrf2 is known to transactivate genes containing the 
antioxidant response cis-elements (ARE) in their promoter region. Nrf2 regulates the 
expression of numerous antioxidant proteins including peroxiredoxins in response to pro-
oxidant conditions in the cell. The PRDX5 mRNA and protein levels were significantly 
decreased in NADK overexpressing cells while knock-down of NADK and thus reduced 
NADPH content increased PRDX5 transcript and protein levels. Significantly elevated Nrf2 
amount was found as a consequence of NADK downregulation, whereas NADK 
overexpression had no significant effect on the Nrf2 transcript level. 
 
3.2 Ca2+/CaM-mediated posttranslational modification of human NADK 
A putative posttranscriptional regulation for human NAD kinase is described (Paper II). The 
protein was shown to be an in vitro substrate for Ca2+/CaM-dependent phosphorylation. The 
serine residue at amino acid position 64 (S64) of NADK was identified as major acceptor site 
which could be phosphorylated by Ca2+/CaM-dependent protein kinase II (CaMKII). This was 
shown by the use of specific inhibitors for CaMKs. The CaMK kinase inhibitor STO-609 did 
not affect phosphorylation of NADK in the presence of Ca2+/CaM while the CaMKII-specific 
inhibitors KN-93 and autoinhibitory peptide (AIP) almost completely abolished the observed 
modification. 
To address a physiological consequence of NADK phosphorylation at S64 the catalytic 
activity of NADK incubated with ATP, Ca2+/CaM and either cell extract or recombinant 
activated CaMKII was determined. No difference in NADK activity could be detected. 
An NADK mutant (S64D) was generated, in which S64 was replaced by an aspartate residue, 
in order to mimic the constitutively phosphorylated form. The NADK S64A mutant could be 
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used as the constitutively unphosphorylated form. The proteins were expressed in E. coli and 
the catalytic activity of the purified proteins determined. The generated mutant NADK 
proteins displayed no significant difference in activity compared to the wild-type protein. 
Further analysis of the NADK amino acid sequence revealed that the negative charge 
introduced into NADK S64D could be insufficient to mimic phosphorylation due to the 
adjacent positively charged Arg63. However, the generated recombinant double mutant 
protein (R63E/S64D) exhibited similar activity as the wild-type NADK. Furthermore, the 
NADK activity in extracts of human cells overexpressing the generated NADK mutants was 
assayed. No significant difference could be detected. 
Phosphorylation of a protein can lead to a change of the subcellular localization. Transiently 
overexpressed, FLAG-tagged NADK wild-type and mutant proteins were all detected in the 
cytoplasm. In addition, FLAG-tagged wild-type NADK was co-expressed with αCAMKII, 
wild-type or constitutively active form. Double immunostaining showed NADK and 
αCAMKII to be exclusively expressed in the cytoplasm. 
 
3.3 Identification of two CaM-activated NADK isoforms from sea urchin 
Two NADK isoforms (SpNADK-1 and SpNADK-2) in the sea urchin S. purpuratus were 
identified (Paper III). The isoforms are encoded by the same gene and differ only in their N-
terminal sequences while the C-terminal regions, which include the catalytic domain, are 
identical. Presence of the transcripts for SpNADK-1 and SpNADK-2 in sea urchin eggs was 
confirmed by RT-PCR analysis. The open reading frames of the identified SpNADKs were 
overexpressed as N-terminally His-tagged proteins in E. coli, purified and characterized. 
Both SpNADK isoforms catalyzed the phosphorylation of NAD+ in the presence of ATP at a 
rate of about 1.8 and 0.6 U/mg for isoform 1 and 2. NADH phosphorylation was hardly 
detectable suggesting NAD+ to be the preferred substrate. Similar to NADH, both sea urchin 
NADKs did not accept NAAD as substrate. Thus, the potent endogenous Ca2+-mobilizing 
molecule NAADP does not seem to be directly produced by these two NADK isoforms. 
Next, I investigated whether sea urchin NADKs are regulated by Ca2+/CaM. Indeed, the 
purified recombinant SpNADKs were significantly stimulated by CaM in the presence of 
Ca2+, although the affinity to CaM was remarkably different. The maximal stimulation by 
CaM (at saturation) was ~4-fold for SpNADK-1 and 2.5-fold for SpNADK-2. Using N-
terminally truncated deletion mutants, the CaM-interacting region of SpNADK isoform 1 was 
shown to be located within amino acids 30-90. Deletion of the first 30 amino acids of 
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SpNADK-1 neither changed the catalytic activity nor the activation by Ca2+/CaM of the 
recombinant mutant protein. In contrast, a deletion mutant lacking amino acids 1-91 was 
catalytically active as SpNADK-1 wild-type but did not respond to CaM. 
In addition to a direct CaM-mediated activation, SpNADK-1 was shown to be an in vitro 
substrate for phosphorylation by CaMKII while this modification was not observed for 
SpNADK-2. Incubation of SpNADK-1 with extracts from human cells overexpressing rodent 
αCaMKII highly increased the incorporation of 32P-phosphate into isoform 1. The 
modification of SpNADK-1 was strongly inhibited by CaMKII-specific autoinhibitory 
peptide. Since SpNADK-2 was not phosphorylated, I speculated the phosphorylation site(s) in 
SpNADK-1 to be located within the N-terminal part of the protein. The deletion mutant 
lacking the first 30 amino acids of SpNADK-1 was hardly phosphorylated compared to the 
full length protein. Alanine mutation of the serine residue at position 18 (S18A) prevented the 
CaM-mediated phosphorylation of SpNADK-1. Together, these results established S18 of 
SpNADK-1 as CaMKII-specific phosphorylation site. 
The structural differences in the N-termini of the two NADK isoforms could influence their 
subcellular localization. To investigate this possibility, the cDNA encoding the C-terminal 
FLAG-tagged SpNADK isoforms was overexpressed in a human cell line. Indirect 
immunocytochemistry revealed both SpNADK proteins to be localized in the cytoplasm. 
The primary structures of human and sea urchin NADKs are highly similar. Thus it was 
attractive to test whether a substitution of the first 91 amino acids of human NADK by the 
corresponding N-terminal region of SpNADK-1 could confer sensitivity to Ca2+/CaM. This 
generated chimeric protein was expressed in E. coli, exhibited normal activity but did not 
respond to Ca2+/CaM. 
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4 DISCUSSION 
4.1 Functional consequences of NADK up- and downregulation in human cells 
The study presented in Paper I demonstrates an important role of NADK in the regulation of 
the cellular NADP pool in human cells. Recombinantly expressed NADK phosphorylated 
both, NAD+ and NADH however the oxidized form appeared to be the preferred substrate. 
This is strenghtened by the fact that the cellular NAD+ content is ~3-10 fold higher than 
NADH (Zhang et al., 2002). Since modulation of cytoplasmic NADK expression was only 
reflected in significant changes of NADPH, it is likely that the generated NADP+ is 
subsequently reduced by cytoplasmic NADP+-specific dehydrogenases. It is known, that the 
rather low concentration of NADP in human cells is maintained in the reduced form under 
normal conditions. Thereby, reducing equivalents are available upon prooxidant conditions. 
Stable overexpression of NADP+-dependent dehydrogenases resulted in a 3 - 4.5-fold increase 
in activity (Salvemini et al., 1999; Jo et al., 2001). Compared to these levels, the 
approximately 200-fold increase in NADK activity in the overexpressing cell line is very high 
but resulted only in a 4-5-fold increase in NADPH. This suggests that human NADK might be 
inhibited by an excess of NADPH which is known for several NADKs (Kawai et al., 2001b; 
Raffaelli et al., 2004; Shi et al., 2005; Grose et al., 2006). 
NADPH is a key player in anti-oxidative defense mechanisms. However, the significant 
changes of the NADPH content in the generated cell lines affected the endogenous ROS 
levels only moderately. Furthermore, knock-down of NADK had no impact on cell survival 
after exposure to oxidative stress conditions. In contrast, an increase of the NADP+-
synthesizing capacity provided better protection towards oxidative stress conditions induced 
by hydrogen peroxide. Another oxidative stimulus, menadione, had no significant effect on 
the cell viability of HEK293 cells. This might be explained by differences in the metabolism 
of these agents and therefore the involvement of different pathways as it was reported for S. 
cerevisiae (Thorpe et al., 2004) and A. nidulans (Pocsi et al., 2005). It is likely, that the rather 
moderate extent of protection against hydrogen peroxide-induced damage, which does not 
correlate with the 4-5 fold increase of the NADPH concentration, is due to the normal content 
of NADP+-dependent dehydrogenases. The role of these enzymes in the cell response to 
oxidative stress is well established. They maintain the NADPH pool which is involved in the 
regeneration of oxidized glutathione and thioredoxin via their reductase activities. Several 
studies have shown that NADP+-specific dehydrogenases are transiently upregulated under 
conditions of oxidative stress (Ursini et al., 1997; Jo et al., 2001; Lee et al., 2004; Vasiliou 
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and Nebert, 2005). In contrast, no increase of human NADK activity or its protein content 
could be detected following treatment of untransfected HeLa or HEK293 cells with oxidizing 
agents. An explanation could be that cells, when exposed to oxidants, rather rely on the 
existing NADP pool and enhance the capacity of keeping it in a reduced state by increased 
expression of NADP+-dependent dehydrogenases. Although the reason to not additionally 
increase the NADP+ concentration is not obvious, at least in the human system there is more 
variety in the sets of enzymes that can re-reduce NADP+ than to produce it. 
Additionally, the results indicate the absence of other genes coding for an NADK in human 
cells which is in striking contrast to yeast and plants (reviewed in (Pollak et al., 2007)). 
Notably, an NADK with slightly different molecular and kinetic properties is decribed in 
human neutrophiles (Williams and Jones, 1985). However, knock-down of NADK in 
HEK293 correlated with the protein level, the activity and the NADP concentrations 
suggesting that the remaining expression of the known NADK gene is responsible for the 
residual NADK activity. With regard to this consideration the question remains how the 
subcellular pools of NADP are generated, compartmentalized and regulated in mammalian 
cells. Especially the mitochondrial DNA (mtDNA) is highly exposed to oxidative attacks 
caused by ROS produced by electron leakage during oxidative phosphorylation (Yakes and 
Van Houten, 1997). Importantly, damage to mtDNA is now emerging as an etiological factor 
in oxidative stress-related disorders but also normal aging (Melov et al., 1999). To diminish 
ROS-induced damage, mitochondria contain numerous antioxidant enzymes and a GSH/Trx 
pool which is dependent on mitochondrial NADPH. In mammals, mitochondrial NADPH is 
provided by NADP+-dependent isocitrate dehydrogenase (Jo et al., 2001), malic enzyme 
(Bukato et al., 1995) and nicotinamide nucleotide transhydrogenase (Rydstrom, 2006). 
Strikingly, yeast cells obviously lack the enzyme nicotinamide nucleotide transhydrogenase 
(Rydstrom et al., 1976) but possess a mitochondrial NADK isoform highly specific for 
NADH as substrate (Outten and Culotta, 2003). This isoform was demonstrated to be the most 
critical generator of NADPH in yeast (Outten and Culotta, 2003; Strand et al., 2003). The 
plant homologue also prefers NADH but was shown to be a cytosolic protein (Turner et al., 
2005; Chai et al., 2006). In contrast to human and yeast, an exchange of NADP across the 
cytosol and the mitochondria is described for plant cells (Bykova and Moller, 2001). The 
apparent absence of a mitochondrial human NADK isoform and the lack of evidence for an 
exchange of NADP across the cytosol and the mitochondria raises the question how the 
human mitochondrial NADPH pool is maintained. It will be interesting to determine whether 
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modulation of NADK expression and thus NADP pool affects the expression or activity of 
mitochondrial NADPH sources. 
Finally, the dramatic redox shift in the generated cell lines is accompanied by changes in the 
transcription levels of PRDX5 and Nrf2. PRDX5 is mainly localized to the mitochondria but 
also found in other compartments (Knoops et al., 1999; Kropotov et al., 1999; Yamashita et 
al., 1999). The promoter of the PRDX5 gene contains clusters of AREs, which the 
transcription factor Nrf2 can bind to (Kropotov et al., 2006). Under normal conditions Nrf2 is 
complexed with Keap1 in the cytoplasm. Oxidative or electrophilic stress induces 
translocation of Nrf2 in the nucleus, where it activates transcription of ARE-regulated genes 
that protect against oxidative cell damage. Therefore, the Keap1/Nrf2 complex was proposed 
to constitute a cellular redox sensor through which the activation of ARE-dependent genes in 
response to oxidative stress is regulated (Itoh et al., 1999). A reduced cellular NADPH 
content, equal to moderate stress condition, resulted in increased expression levels of PRDX5 
and Nrf2. These observations suggest the possiblity that expression of PRDX5 can be 
regulated by Nrf2 in response to the redox state and that PRDX5 might serve as a redox buffer 
which is adjusted according to the reservoir of the ultimate regeneration source of the 
oxidative defense systems. Whether the changes in NADPH directly alter PRDX5 or Nrf2 
function or whether other mechanisms are involved, remains to be elucidated. Recently it was 
shown that NAD redox changes can regulate transcription of the NAD+-dependent protein 
deacetylase SIRT1 (Zhang et al., 2007). This report and the present study highlight an 
additional function of pyridine nucleotides, namely a possible role in dynamic and specific 
transcriptional regulation in response to metabolic changes in the cell. 
The presented results suggest striking differences in regulation of the human NADP 
metabolism by NADK compared to yeast and plant. These include the number of NADK 
isoforms, their cellular localization and substrate specificity. Further investigations are 
necessary to complete our understanding of the pathways and molecular mechanisms of 
NADP generation and its regulatory functions. This could provide new insights how to cope 
with the many pathological conditions that involve oxidative damage. 
 
4.2 Ca2+/CaM-mediated posttranslational modification of human NADK 
The results presented in Paper II establish human NADK to be phosphorylated in response to 
Ca2+/CaM. The CaMKII-dependent phosphorylation site was located within the N-terminal 
part of the protein. A deletion mutant of NADK lacking the first 64 amino acids abolished the 
phosphorylation by CaMKII but fully retained the catalytic activity. This finding together 
33 
with the observation that the CaM-mediated regulation of sea urchin NADK isoforms is 
associated with the different N-termini (Paper III) highlight the importance of the N-terminal 
region of NADKs as a regulatory domain. In agreement with these results, it was shown that 
the large N-terminal extension of plant NADK isoform 2 is involved in binding of CaM 
(Turner et al., 2004) and serine residues within the N-terminal part of mouse NADK were 
identified as specific phosphorylation sites (Villen et al., 2007). 
The results of this study appear to rule out, at least for the known human NADK, that CaM-
mediated phosphorylation is sufficient for the stimulation of NADK: the catalytic activity of 
the enzyme incubated with ATP, Ca2+/CaM and either cell extract or recombinant CaMKII 
was not significantly altered. Furthermore, the specific activities of mutant NADK proteins, 
which either mimicked or excluded the phosphorylation at S64, were unchanged compared to 
that of the wild-type. 
As partially purified NADK from human neutrophils is activated directly by Ca2+/CaM 
(Williams and Jones, 1985) it is likely that multiple human NADK isoforms exist, which are 
specifically expressed in cells involved in the regulation of immune response. It would be 
interesting to purify NADK from human neutrophils and to determine the N-terminal amino 
acid sequence for comparison with the known human NADK. Alternatively, if CaM-
dependent phosphorylation has a role in regulating the activity of human NADK, there could 
be additional regulatory factors involved. Recently, a mass spectrometry-based analysis of 
mouse liver protein phosphorylation identified two phosphorylation sites in mouse NADK, 
namely the serine residues 48 and 64 (Villen et al., 2007). This result raises the possibility that 
synergistic effects are needed to fully activate NADK in response to Ca2+/CaM. A comparison 
of the amino acid sequences of the human and a putative mouse NADK revealed very high 
similarity even in the N-terminal part. In particular the region between amino acids 40-70 is 
nearly identical. It is tempting to speculate the serine residue 48 (S48) of human NADK to be 
an additional phosphorylation site. Substitution of this residue by alanine had at least no effect 
on the CaMKII-mediated phosphorylation of NADK. 
Phosphorylation can influence the subcellular localization of the target protein (Kwiek et al., 
2007). A phosphorylation state-dependent subcellular distribution of the only known human 
NADK could explain the generation of NADP pools in compartments that do not exchange 
this nucleotide with the cytosol such as the mitochondria. Overexpression of the mutant 
NADKs mimicking or excluding phosphorylation (NADK S64A, S64D and R63E/S64D) 
resulted in cytoplasmic localization which is the same as found for the wild-type protein 
(Paper I). Furthermore, co-expression of NADK and αCaMKII did also not alter the 
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subcellular localization of human NADK. These observations are consistent with the 
predicted subcellular localization of the enzyme (PSORT II algorithm) and with the lack of 
any putative targeting sequence motifs. 
In conclusion, this study clearly established human NADK as a specific target of CaMKII-
mediated phosphorylation. Taking into consideration a recent proteomic study ((Villen et al., 
2007), this modification occurs in S64 of the protein and is most likely of physiological 
relevance. However, the actual effect of the modification remains to be identified. Further 
studies are needed to establish whether the phosphorylation, for example, alters the protein 
stability or mediates interactions with other proteins. 
 
4.3 Identification of two CaM-activated NADK isoforms from sea urchin 
In the study presented in Paper III, two NADK isoforms of the sea urchin S. purpuratus were 
identified. Both isoforms are directly activated by Ca2+/CaM however the affinity to CaM and 
the extent of the stimulation vary. Furthermore, isoform 1 was shown to be a target for 
Ca2+/CaM-dependent phosphorylation by CaMKII. 
Ca2+-signaling has a critical role in fertilization and activation of sea urchin NADK is known 
to be one of the earliest Ca2+-mediated events in the activation of the sea urchin egg. Various 
postfertilization processes depend on NADPH synthesized from NADP+ by the pentose 
phosphate pathway. The results establish for the first time the molecular basis for this increase 
in NADPH shortly after fertilization. That is, an increase in Ca2+ leads to direct activation of 
NADKs via CaM and thereby increased production of NADPH. 
The major structural differences among known eukaryotic NADKs are found within the N-
terminal region (reviewed in (Pollak, 2007)). Remarkably, both sea urchin NADKs share high 
similarity to each other as well as to the human NADK besides the first 60 amino acids. The 
CaM-mediated stimulation of both sea urchin NADKs and the phosphorylation of SpNADK-1 
were mapped to the N-terminal parts. Deletion of amino acids 1-91 of SpNADK-1 (resulting 
in the identical protein for both SpNADK isoforms) had no effect on the catalytic activity but 
abolished both CaM-dependent events. Thus, the different N-terminal parts of SpNADKs 
were established to be important as a regulatory domain. 
Interestingly, the CaMKII-dependent phosphorylation of SpNADK-1 suggests regulation of 
NADK activity by an additional Ca2+/CaM-mediated pathway. In fact, this possibility could 
explain the reported stimulation of NADK activity by Ca2+/CaM in tissue or cell extracts from 
plants and humans (Anderson et al., 1980; Dieter and Marme, 1984; Williams and Jones, 
1985). In contrast, none of the purified recombinant NADKs from A. thaliana as well as the 
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human enzyme were activated by Ca2+/CaM (Lerner et al., 2001; Turner et al., 2004; Turner 
et al., 2005). Since measurement of NADK activity requires the addition of ATP, CaM-
dependent phosphorylation events could have taken place in the crude extracts or partially 
purified enzymes. 
NAADP is an important calcium releasing messenger in sea urchin eggs (for a review see 
(Whitaker, 2006)). It was suggested that NAADP could be generated by NADK via 
phosphorylation of the physiological intermediate NAAD (Ziegler, 2000). However, similar 
to the human NADK (Lerner et al., 2001), such an activity for both SpNADKs was not 
detectable whether or not CaM was present. There might be a yet not identified kinase 
specific for NAAD phosphorylation. 
Both, yeast and plant cells encode three NADK isoforms which differ in their subcellular 
localization and contribution to the subcellular NADP pools (Outten and Culotta, 2003; Berrin 
et al., 2005; Chai et al., 2005; Bieganowski et al., 2006; Chai et al., 2006). NADK activity in 
sea urchin eggs was found in the cytoplasmic supernatant fraction (Epel, 1967). Furthermore, 
the PSORT II algorithm predicts both SpNADKs to be cytoplasmic. Indeed, overexpression 
of the cDNAs encoding SpNADKs in a human cell line followed by indirect 
immunocytochemistry revealed both isoforms to be present in the cytoplasm. To confirm this 
observation, it would be interesting to study the distribution of the endogenous SpNADKs. A 
polyclonal antibody raised against the purified human NADK did not reveal specific detection 
of SpNADKs in western blot analysis. Therefore it is necessary to produce specific antibodies 
against both isoforms. 
It will be important to investigate the contribution of the two NADK isoforms to maintain the 
NADP pool in sea urchin, in particular at fertilization or under oxidative stress conditions. 
Since activation of NADK is suggested to be an important step for the progress of 
fertilization, one could speculate that inhibition of SpNADKs blocks or delays 
postfertilization processes. It will also be interesting to elucidate the physiological role of the 
CaMKII-mediated phosphorylation of SpNADK-1. CaMKII has been reported as a critical 
link between sufficiently high NADPH levels and cell survival during Xenopus development 
(Nutt et al., 2005) and to be required for nuclear envelope breakdown during mitotic division 
of sea urchin embryos (Baitinger et al., 1990). Moreover, Ca2+-signaling, particularly 
involving CaMKII, is a major system which is activated under conditions of oxidative stress 
(reviewed in (Franklin et al., 2006)). Since NADPH is essential to all mechanisms 
counteracting oxidative damage, the CaMKII-dependent phosphorylation of SpNADK 
isoform 1 could be a key regulatory step to ensure sufficient amounts of NADPH. 
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